Cargando…
Current management options for latent tuberculosis: a review
Tuberculosis remains the world’s second leading infectious cause of death, with nearly one-third of the global population latently infected. Treatment of latent tuberculosis infection is a mainstay of tuberculosis-control efforts in low-to medium-incidence countries. Isoniazid monotherapy has been t...
Autores principales: | Norton, Brianna L, Holland, David P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514970/ https://www.ncbi.nlm.nih.gov/pubmed/23226700 http://dx.doi.org/10.2147/IDR.S29180 |
Ejemplares similares
-
Management of Latent Tuberculosis Infections in Australia and New Zealand: A Review of Current Practice
por: Denholm, Justin T., et al.
Publicado: (2010) -
Current and emerging treatment options in the management of lupus
por: Jordan, Natasha, et al.
Publicado: (2016) -
Tuberculosis Infection and Latent Tuberculosis
por: Lee, Seung Heon
Publicado: (2016) -
Updates on the risk factors for latent tuberculosis reactivation and their managements
por: Ai, Jing-Wen, et al.
Publicado: (2016) -
Management of pheochromocytomas and paragangliomas: Review of current diagnosis and treatment options
por: Eid, Michal, et al.
Publicado: (2023)